Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cesare Gridelli

Showing results (121-130 of 357) with videos related to

Pageof 36
Sort By:
Journal of Thoracic Disease|June 29, 2018
Lung cancer, elderly and immune checkpoint inhibitorsFrancesca Casaluce, Assunta Sgambato, Paolo Maione, et al.
Critical Reviews in Oncology/Hematology|March 3, 2009
Second and third line treatment in non-small cell lung cancerAdolfo Favaretto, Giulia Pasello, Cristina Magro, et al.
Cancer|January 19, 2010
Treatment of small-cell lung cancer in elderly patientsAthanasios G Pallis, Frances A Shepherd, Denis Lacombe, et al.
Expert Review of Anticancer Therapy|January 6, 2022
Chemotherapy plus single/double immunotherapy in the treatment of non-oncogene addicted advanced non-small cell lung cancer: where do we stand and where are we going?Danilo Rocco, Luigi Della Gravara, Nicola Franzese, et al.
Journal of Cellular Physiology|May 17, 2005
Trying to compose the puzzle with all the pieces: epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancerMassimo Di Maio, Cesare Gridelli, Nicola Normanno, et al.
Lung Cancer (Amsterdam, Netherlands)|July 7, 2009
Pemetrexed in the treatment of advanced non-squamous lung cancerAntonio Rossi, Serena Ricciardi, Paolo Maione, et al.
Translational Cancer Research|February 4, 2022
Second-line avelumab in platinum-treated non-small cell lung cancer patients: comment on the JAVELIN Lung 200 clinical trialDanilo Rocco, Luigi Della Gravara, Umberto Malapelle, et al.
International Journal of Molecular Sciences|February 11, 2023
Treatment of Advanced Non-Small Cell Lung Cancer with RET Fusions: Reality and HopesDanilo Rocco, Luigi Sapio, Luigi Della Gravara, et al.
Expert Opinion on Pharmacotherapy|July 20, 2021
The treatment of advanced lung adenocarcinoma with activating EGFR mutationsDanilo Rocco, Luigi Della Gravara, Ciro Battiloro, et al.
International Journal of Oncology|May 27, 2014
Diagnostic and therapeutic issues for patients with advanced non‑small cell lung cancer harboring anaplastic lymphoma kinase rearrangement: European vs. US perspective (review)Massimo Di Maio, Filippo De Marinis, Fred R Hirsch, et al.
Pageof 36

Showing results (121-130 of 357) with videos related to

Sort By:
Pageof 36
Journal of Thoracic Disease|June 29, 2018
Lung cancer, elderly and immune checkpoint inhibitorsFrancesca Casaluce, Assunta Sgambato, Paolo Maione, et al.
Critical Reviews in Oncology/Hematology|March 3, 2009
Second and third line treatment in non-small cell lung cancerAdolfo Favaretto, Giulia Pasello, Cristina Magro, et al.
Cancer|January 19, 2010
Treatment of small-cell lung cancer in elderly patientsAthanasios G Pallis, Frances A Shepherd, Denis Lacombe, et al.
Expert Review of Anticancer Therapy|January 6, 2022
Chemotherapy plus single/double immunotherapy in the treatment of non-oncogene addicted advanced non-small cell lung cancer: where do we stand and where are we going?Danilo Rocco, Luigi Della Gravara, Nicola Franzese, et al.
Journal of Cellular Physiology|May 17, 2005
Trying to compose the puzzle with all the pieces: epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancerMassimo Di Maio, Cesare Gridelli, Nicola Normanno, et al.
Lung Cancer (Amsterdam, Netherlands)|July 7, 2009
Pemetrexed in the treatment of advanced non-squamous lung cancerAntonio Rossi, Serena Ricciardi, Paolo Maione, et al.
Translational Cancer Research|February 4, 2022
Second-line avelumab in platinum-treated non-small cell lung cancer patients: comment on the JAVELIN Lung 200 clinical trialDanilo Rocco, Luigi Della Gravara, Umberto Malapelle, et al.
International Journal of Molecular Sciences|February 11, 2023
Treatment of Advanced Non-Small Cell Lung Cancer with RET Fusions: Reality and HopesDanilo Rocco, Luigi Sapio, Luigi Della Gravara, et al.
Expert Opinion on Pharmacotherapy|July 20, 2021
The treatment of advanced lung adenocarcinoma with activating EGFR mutationsDanilo Rocco, Luigi Della Gravara, Ciro Battiloro, et al.
International Journal of Oncology|May 27, 2014
Diagnostic and therapeutic issues for patients with advanced non‑small cell lung cancer harboring anaplastic lymphoma kinase rearrangement: European vs. US perspective (review)Massimo Di Maio, Filippo De Marinis, Fred R Hirsch, et al.
Pageof 36